Zexing Shan

Shenyang, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Bismuth Quadruple Therapy as an Unstable Benchmark for Noninferiority.

Bismuth Quadruple Therapy as an Unstable Benchmark for Noninferiority.

Journal: Gastroenterology

Published: March 19, 2026

MFAP2 secreted by TGF-β1-induced cancer-associated fibroblast cells promotes gastric cancer peritoneal metastasis through Src-STAT3-PTK7 axis.

MFAP2 secreted by TGF-β1-induced cancer-associated fibroblast cells promotes gastric cancer peritoneal metastasis through Src-STAT3-PTK7 axis.

Journal: Cell death discovery

Published: March 06, 2026

Targeting ferroptosis, pyroptosis and necroptosis for cancer immunotherapy in melanoma: mechanistic insights and clinical perspectives.

Targeting ferroptosis, pyroptosis and necroptosis for cancer immunotherapy in melanoma: mechanistic insights and clinical perspectives.

Journal: Frontiers in immunology

Published: May 16, 2025

Harnessing glycolysis in gastric cancer: molecular targets, therapeutic strategies, and clinical horizons.

Harnessing glycolysis in gastric cancer: molecular targets, therapeutic strategies, and clinical horizons.

Journal: Frontiers in immunology

Published: May 15, 2025

Opportunities, obstacles and challenges of nano-immunotherapy in melanoma.

Opportunities, obstacles and challenges of nano-immunotherapy in melanoma.

Journal: Frontiers in immunology

Published: April 14, 2025

Metabolic Reprogramming of Gastric Cancer Revealed by a Liquid Chromatography-Mass Spectrometry-Based Metabolomics Study.

Metabolic Reprogramming of Gastric Cancer Revealed by a Liquid Chromatography-Mass Spectrometry-Based Metabolomics Study.

Journal: Metabolites

Published: February 15, 2025

CYP19A1 Silencing Inhibits Cell Proliferation and Endoplasmic Reticulum Stress in Stomach Adenocarcinoma.

CYP19A1 Silencing Inhibits Cell Proliferation and Endoplasmic Reticulum Stress in Stomach Adenocarcinoma.

Journal: Oncology research

Published: December 13, 2024

Advances in immunotherapy for mucosal melanoma: harnessing immune checkpoint inhibitors for improved treatment outcomes.

Advances in immunotherapy for mucosal melanoma: harnessing immune checkpoint inhibitors for improved treatment outcomes.

Journal: Frontiers in immunology

Published: May 31, 2024

Extracellular vesicles in gastric cancer: role of exosomal lncRNA and microRNA as diagnostic and therapeutic targets.

Extracellular vesicles in gastric cancer: role of exosomal lncRNA and microRNA as diagnostic and therapeutic targets.

Journal: Frontiers in physiology

Published: February 04, 2023

Predictive value of NLR and PLR in response to preoperative chemotherapy and prognosis in locally advanced gastric cancer.

Predictive value of NLR and PLR in response to preoperative chemotherapy and prognosis in locally advanced gastric cancer.

Journal: Frontiers in oncology

Published: May 05, 2022

Genome-Scale Analysis Identified NID2, SPARC, and MFAP2 as Prognosis Markers of Overall Survival in Gastric Cancer.

Genome-Scale Analysis Identified NID2, SPARC, and MFAP2 as Prognosis Markers of Overall Survival in Gastric Cancer.

Journal: Medical science monitor : international medical journal of experimental and clinical research

Published: March 24, 2021

CA724 Predicts Tumor Regression Grade in Locally Advanced Gastric Cancer Patients with Neoadjuvant Chemotherapy.

CA724 Predicts Tumor Regression Grade in Locally Advanced Gastric Cancer Patients with Neoadjuvant Chemotherapy.

Journal: Journal of Cancer

Published: March 21, 2021

Showing 1-12 of 17

Last Updated: 09/26/2026